time required for stem cells to reconstitute sufficiently a large reservoir; later, hematopoiesis is maintained by the Allogeneic bone marrow transplant recipients maintain progeny of relatively few cells.
reduction of the stem cell reservoir after allogeneic bone
The information concerning the recovery of early and marrow transplantation.
committed stem cell compartments in long-term survivors Keywords: LTC-IC; allogeneic bone marrow transplant; after allogeneic bone marrow transplant is so far scarce. long-term survivors We are aware that quantitative assessment of hemopoiesis, as performed by detecting the frequency of a given cell population, is a difficult task. A non-homogeneous distriSeveral lines of evidence suggest that two or three distinct bution of bone marrow cellularity, different volumes of subpopulations of progenitor cells are responsible for shortmarrow aspirated and therefore variable contamination with and long-term hemopoietic reconstitution after bone marblood may preclude uniformity of sampling. row transplantation (BMT) in the animal model. 1,2 Some We have studied LTC-IC frequency in 64 patients at a progenitors can rapidly provide a great number of differenmedian interval of 6 years (range 2-20) from allogeneic tiated cells in all lineages but not durable engraftment in BMT. This primitive population (LTC-IC) can be separirradiated animals. Other multipotent cells have been shown ated, in humans, from the clonogenic compartment by a to sustain engraftment, but require weeks or months before number of physical and antigenic properties such as high proliferation and differentiation occur in vitro or in vivo. 3, 4 level of CD34 antigen expression. Moreover, it has been However, the lineage relationship and overall contributions shown in the mouse, that such hemopoietic cells are capof each of these classes of hematopoietic stem cells to able of clonal expansion in vitro with preservation of both normal hemopoiesis is still unclear.
their long-term and competitive repopulating abilities. 15, 16 In large animals, two phases of stem cell kinetics have Other end points were bone marrow cellularity and the been observed: initially, there are consistent fluctuations in number of committed progenitors (CFU-GM, BFU-E, the contributions of stem cell clones, possibly reflecting the CFU-GEMM). Variables potentially relevant to graft function, such as diagnosis, phase of disease, conditioning regimen, CMV infections, composition of the graft, GVHD and Cultures were fed at weekly interfollowed by total body irradiation (TBI). 17 Transplant vals for 5 weeks, then they were overlayed with semisolid recipients did not receive prophylactic growth factors after culture medium and growth factors as described above. BMT. The median interval between bone marrow transplant After 18-20 days of incubation wells were examined for and clonogenic analyses was 6 years (range [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
the presence of colonies. Statistical analyses were carried out using Student's t-test (NCSS package, JL Hintze, Kaysville, UT, USA, 1990).
Normal controls
Thirty heparinized marrow samples were obtained from allogeneic donors providing marrow for transplantation, in Results order to supply both control studies and stromal layers for the LTC-IC assay. All donors gave their informed consent. Cellularity
All patients had normal blood cells counts at the time of Clonogenic assays our observations. Bone marrow cellularity ranged between 40 and 100% with a median value of 80% (Tables 1-3 ). Bone marrow mononuclear cells were isolated by centrifugAll lineages were well represented and normally distribation on 1.077 g/ml Ficoll-Hypaque (Pharmacia Biotech, uted. No remarkable differences were noted with respect to Uppsala, Sweden) to eliminate the majority of erythrocytes, time from transplant. granulocytes and platelets. The cells were then washed twice in Iscove's modified Dulbecco's medium (IMDM; MA Product, Walkersville, MD, USA) containing 5% fetal Marrow progenitors calf serum (FCS, Hyclone, Logan, UT, USA) and resusTransplanted patients had CFU-GM and BFU-E numbers pended in the same medium. MNC (10 5 ) were plated in similar to normal controls: 66.1 ± 5.4/10 5 MNC vs 1.1 ml semisolid culture medium consisting of IMDM sup-66.0 ± 6.0 (P = 0.9) and 12.9 ± 1.2 vs 8.1 ± 0.8 (P = 0.03) plemented with antibiotics (penicillin/streptomycin; Gibco), respectively ( Figure 1) ; on the contrary, CFU-GEMM were 0.9% methylcellulose (Sigma, St Louis, MO, USA), 30%
found to be decreased (3.1 ± 0.4/10 5 MNC vs 1.2 ± 0.2 FCS, 1% crystallized bovine serum albumin (Sigma), P = 0.001). LTC-IC frequency was still lower when 10 −4 mol/l mercaptoethanol (2ME; Sigma, final compared to controls 3.2 ± 0.6/10 6 MNC vs 54.2 ± 9.3 concentration), rhGM-CSF (10 ng) (Genzyme Corporation, (P = 0.0001) (Figure 1 ). Cambridge, MA, USA), rhIL3 (50 ng) (Sandoz International, Basel, Switzerland), rhG-CSF (10 ng) (HoffmanLa Roche, Wyhlen, Germany) and 4 U erythropoietin Time from transplant (Genzyme). After 14 days of incubation in a humidified atmosphere at 37°C and 5% CO 2 , colonies (CFU-GM, CFU-GM rapidly increased within the first 2 years to reach BFU-E and CFU-GEMM) were classified and counted in and maintain normal values ( Figure 2 ). In contrast, the frethe same dish using an inverted microscope. Patient variables dishes over a confluent feeder layer of irradiated normal marrow cells or over a murine irradiated cell line (M2-Type of disease did not influence the number of committed progenitors (CFU-GM and BFU-E) after they reached the 10B4, kindly provided by Dr C Eaves).
18 LTC-IC were maintained for 3 days at 37°C, then switched to 33°C and normal range (Tables 1, 2 and 3) . 
Cell % = marrow cellularity; CFU-GM = colony-forming unit granulocyte-macrophage; BFU-E = burst-forming unit-erythroid; CFU-GEMM = colonyforming unit granulocyte-erythrocyte-macrophage-megakaryocyte; LTC-IC = long-term culture initiating cell; UPN = unique patient number.
* PNH = Paroxysmal nocturnal haemoglobinuria. CFU-GEMM numbers were significantly lower than norMales showed a better recovery of LTC-IC than females (4.3 ± 0.8/10
6 vs 1.6 ± 0.5; P = 0.002), but still significantly mal controls (P = 0.001, Figure 1) . Type of the disease did not influence the number of CFU-GEMM: SAA vs AL lower than normal controls (54.2 ± 9.3) (Figure 1 ). Donor gender and sex match were not predictive for (P = 0.2), SAA vs CML (P = 0.4); AL vs CML (P = 0.06).
LTC-IC frequencies were respectively: 2.4 ± 0.7/10 6 (in numbers of LTC-IC. Male donors were also non-predictive (MF vs FM: P = 0.09). 28 AL patients, P = 0.0001); 3.8 ± 1.1 (in 15 CML patients, P = 0.0001) and 3.8 ± 1 (in 19 SAA patients, P = 0.0001).
Phase of the disease did not influence the number of Limiting dilution studies LTC-IC: first remission patients 2.5 ± 0.6/10 6 vs 3.7 ± 2.8 for patients in more advanced phase of the disease In our laboratory each LTC-IC from normal marrow was found to produce a median of three CFCs (range 1-16) (P = 0.4). detectable after 5 weeks of culture (data not shown). To method to derive the frequency of LTC-IC in the starting population. 19, 20 The average proliferative potential of LTCinvestigate whether transplanted patients had a qualitatively different population, we plated bone marrow cells in limit-IC from each patient was then calculated dividing the total numbers of CFC present by the number of derived LTCing dilution. The number of negative assay cultures was analyzed using Poisson statistics and the weighted-mean IC in the same culture. In transplanted patients (three cases Years from transplant tested) the median number of CFC derived from each LTCTransplant variables IC was 3.0 (range 2.9-3.1) (Table 4) , not significantly
Patients received a median number of 3.3 × 10 8 /kg MNC: different from normal controls (P = 0.5).
LTC-IC frequency did not increase in the group infused with greater numbers of MNC as compared to the others (Ͼ3.3 × 10 8 /kg: 2.9 ± 0.7/10 6 ; Ͻ3.3 × 10 8 /kg: 3.4 ± (4.9 ± 1.8 vs 3.0 ± 1.1, P = 0.3); moreover, clonogenic cells (CFU-GM and BFU-E) in the two groups did not differ 95% CL = 95% confidence limits.
significantly (46.1 ± 8.8 vs 70 ± 17.6, P = 0.3).
Conditioning regimens did not seem to influence longHow can we explain the reduced number of early hemopoietic cells long-term after transplant? First of all, quantiterm hemopoietic reconstitution: SAA patients, who did not receive TBI showed similar LTC-IC frequencies to leuketative assessment of early progenitors in humans is uncertain and many variables such as a non-homogeneous mia patients who were given TBI (3.9 ± 10 vs 2.9 ± 0.6, P = 0.4. Similarly GVHD was not predictive either when distribution of bone marrow cellularity, different amounts of marrow aspiration and contamination with blood, may we considered the acute form (grade 0-II vs III-IV, P = 0.2) or the chronic form of the disease (no or limited be confounding factors. Previous studies have shown that repopulating comvs extensive, P = 0.9).
CMV infection did not seem to affect the hemopoietic petence of the regenerated bone marrow cells is reduced about 10-fold after transplantation. 25 This may be due to reservoir. In fact, patients developing CMV had 6.1 ± 1.5 LTC-IC/10 6 MNV vs 2.4 ± 0.4 (P = 0.03) in patients with sustained proliferative stress imposed on at least some of these cells during the early phase of regeneration of the no signs of CMV infection.
system and may result in a decline in their probability of self-renewal in subsequent divisions. A strong proliferative Outcome stimulus is also associated with loss of telomeric DNA, a process involved in proliferative potential decrement of the Eight of 64 patients had relapsed before being studied: two had acute leukemia, and six had CML. Relapsed patients hemopoietic stem cells. 26 On the other hand, the hemopoietic system is regulated to reach normal values in a brief did not have significantly less LTC-IC in their marrow than patients who remained in remission (2.5 ± 1.5 time and to maintain such a steady-state. In fact, blood cell production can be maintained in steady-state by the vs 3.0 ± 0.7, P = 0.5).
progeny of a few cells.
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Moreover, it has been recently shown in the mouse 28 that a relevant expansion of CRU (competitive repopulating Discussion unit) occurs after transplant even though this is insufficient to achieve a stem cell reservoir comparable to imperWe have shown in this study that a severe and persistent defect at the level of early progenitor cells (LTC-IC) exists turbed animals. Hemopoietic progenitors infused in a clinical transplant in the marrow of transplanted recipients, despite normal recovery of committed progenitors and peripheral blood are a small portion of the whole stem cell pool present in a normal individual; some stem cells are lost during the cell counts.
The number of CFU-GM reached normal values within homing process 29 and the host microenvironment has been demonstrated to have a defective capacity of supporting the first 2 years after BMT, and thereafter remained within the normal range. In contrast, LTC-IC frequencies were hemopoiesis. 13 Therefore, what we have shown after BMT is not only an absolute reduction of LTC-IC numbers but found to be very low: one log less when compared to normal controls, for at least 20 years post-BMT, which is our also a limited expansion of such progenitors in the host. In keeping with this hypothesis, recent studies have demonlongest follow-up. Low numbers of LTC-IC did not correlate with type or phase of the diseases, pre-transplant constrated that only engineered overexpression of HOXB4 genes causes selective expansion of more primitive hemoditioning regimens, CMV infections, or sex matching. However, it should be noted that male recipients seemed poietic populations.
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Low LTC-IC frequencies in transplanted patients may to recover better when compared to females (P = 0.09), suggesting a possible role for androgens in this setting.
express the physiological decline of hemopoietic stem cells that in part loose their self-renewal property during regenerIn this study we could find no correlation between the numbers of infused cells or between the CFU-GM content ation of the hemopoietic system after bone marrow transplantation. of the graft and the frequency of LTC-IC post-BMT despite recent studies suggesting an effect of CFU-GM 21 and BFUIn conclusion, long-term survivors after allogeneic bone marrow transplant disclose in their marrow a reduced Mk 22 on early platelet counts and an effect of cell dose on early hematological recovery. 23 Thus, the effect of CFUhemopoietic reservoir that does not seem to perturb more mature compartments. Potential clinical implications of GM infused is representative of hemopoietic cells supporting early engraftment.
these data need further evaluations. The proliferative potential of individual LTC-IC was evaluated by limiting dilution analysis in long-term survivors and appeared to be similar to normal controls: this
